| A27L |
NR-2622 |
The reagent was obtained through the NIH Biodefense and Emerging Infections Research Resources Repository, NIAID, NIH: Vaccinia Virus (WR) A27L Protein with C-terminal Histidine Tag, Recombinant from baculovirus, NR-2622 |
| A33R |
NR-2623 |
The reagent was obtained through BEI Resources, NIAID, NIH: Vaccinia Virus, Western Reserve, A33R Protein with C-Terminal Histidine Tag, Recombinant from baculovirus, NR-2623 |
| B5R |
NR-546 |
The reagent was obtained through the NIH Biodefense and Emerging Infections Research Resources Repository, NIAID, NIH: Vaccinia Virus (WR) B5R Protein with N-terminal Histidine Tag, Recombinant from baculovirus, NR-546 |
| F9L |
NR-2626 |
The reagent was obtained through the NIH Biodefense and Emerging Infections Research Resources Repository, NIAID, NIH: Vaccinia Virus (WR) F9L Protein with C-terminal Histidine Tag, Recombinant from baculovirus, NR-2626 |
| L1 |
NR-2625 |
The reagent was obtained through BEI Resources, NIAID, NIH: Vaccinia Virus, Western Reserve, L1R Protein with C-Terminal Histidine Tag, Recombinant from baculovirus, NR-2625 |
| mAb417 |
NR-417 |
The reagent was obtained through the NIH Biodefense and Emerging Infections Research Resources Repository, NIAID, NIH: Monoclonal Anti-Vaccinia Virus (WR) L1R Protein, Residues 1 to 185 (similar to VMC-2), (produced in vitro), NR-417 |
| mAb418 |
NR-418 |
The reagent was obtained through the NIH Biodefense and Emerging Infectious Research Resource Repository, NIAID, NIH: Monoclonal Anti-Vaccinia Virus (WR) L1R Protein, Residues 1 to 185 (similar to VMC-3), (produced (in vitro), NR-418 |
| mAb419 |
NR-419 |
The reagent was obtained through the NIH Biodefense and Emerging Infectious Research Resource Repository, NIAID, NIH: Monoclonal Anti-Vaccinia Virus (WR) L1R Protein, Residues 1 to 185 (similar to VMC-4), (produced (in vitro), NR-419 |
